TD Securities (USA)’s Biogen BIIB Stock Holding History

TD Securities (USA)’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$13K	Sell	49 -1	-2%	-$264	0.12%	71
2015 Q4	$15K	Sell	50 -84	-63%	-$24.1K	0.14%	65
2015 Q3	$39K	Sell	134 -95,133	-100%	-$31.4M	0.36%	59
2015 Q2	$38.5M	Buy	95,267 +10,985	+13%	+$4.41M	0.52%	44
2015 Q1	$35.6M	Sell	84,282 -5,394	-6%	-$2.13M	0.54%	42
2014 Q4	$30.4M	Buy	89,676 +7,075	+9%	+$2.29M	0.44%	51
2014 Q3	$27.3M	Sell	82,601 -320	-0.4%	-$106K	0.44%	48
2014 Q2	$26.1M	Buy	82,921 +5,346	+7%	+$1.61M	0.42%	51
2014 Q1	$23.7M	Sell	77,575 -5,764	-7%	-$1.83M	0.42%	53
2013 Q4	$23.3M	Buy	83,339 +1,963	+2%	+$508K	0.39%	57
2013 Q3	$19.6M	Buy	81,376 +438	+0.5%	+$98K	0.37%	61
2013 Q2	$17.4M	Buy	+80,938	New	+$17.3M	0.35%	64

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

TD Securities (USA)'s BIIB Position: Q1 2016 in Review

TD Securities (USA) reduced its Biogen (BIIB) stake by 2% in Q1 2016, selling an estimated $264 and leaving 49 shares worth $13K. The position accounts for 0.12% of the portfolio, ranked #71.

TD Securities (USA) first reported a position in BIIB in Q2 2013 and has held it in 12 quarters since. The position peaked at $38.5M in Q2 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

TD Securities (USA) held 49 shares of Biogen worth $13K as of Q1 2016.
TD Securities (USA) sold 1 Biogen share in Q1 2016, an estimated $264.
Biogen made up 0.12% of TD Securities (USA)'s portfolio in Q1 2016, its #71 holding.
TD Securities (USA) first reported a position in Biogen in Q2 2013 and has held it in 12 quarters since.
TD Securities (USA)'s Biogen position peaked at $38.5M in Q2 2015.
948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.